(Q37076476)

18 August 2017

Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia (English)

1 reference

18 August 2017

0 references

1

Haya Ascher-Svanum

1 reference

18 August 2017

Allen W Nyhuis

2

1 reference

18 August 2017

Douglas E Faries

3

1 reference

18 August 2017

Bruce J Kinon

4

1 reference

18 August 2017

Robert W Baker

5

1 reference

18 August 2017

Anantha Shekhar

6

1 reference

18 August 2017

language of work or name

English

0 references

publication date

21 December 2007

1 reference

18 August 2017

Schizophrenia Bulletin

1 reference

18 August 2017

34

1 reference

18 August 2017

6

1 reference

18 August 2017

1163-1171

1 reference

Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Analysis of treatment effectiveness in longitudinal observational data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Remission in schizophrenia: proposed criteria and rationale for consensus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Practice guideline for the treatment of patients with schizophrenia, second edition.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

29 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

29 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

The positive and negative syndrome scale (PANSS) for schizophrenia

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

The MOS 36-ltem Short-Form Health Survey (SF-36)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Rating of medication influences (ROMI) scale in schizophrenia.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Optimizing early prediction for antipsychotic response in schizophrenia.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

What does the PANSS mean?

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Early Prediction of Antipsychotic Response in Schizophrenia

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632496

Discovering the neural basis of human social anxiety: a diagnostic and therapeutic imperative.

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBM134

Selection Bias in Clinical Trials With Antipsychotics

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBM134

How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?

21 January 2018

1 reference

12 December 2020

A population based elaboration of the role of age of onset on the course of schizophrenia

1 reference

12 December 2020

Treatment of schizophrenia 1999. The expert consensus guideline series

1 reference

12 December 2020

Early prediction of antipsychotic nonresponse among patients with schizophrenia

1 reference

12 December 2020

Canadian clinical practice guidelines for the treatment of schizophrenia. The Canadian Psychiatric Association

1 reference

12 December 2020

Identifiers

DOI

10.1093/SCHBUL/SBM134

1 reference

release_z6ilj6p3d5grdkpd2afza2k4se

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z6ilj6p3d5grdkpd2afza2k4se

24 November 2022

mapped directly with Wikidata item

1 reference

18 August 2017

PubMed publication ID

18156640

1 reference